** Shares of ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK slump 11.2% to HK$7.48, on course for the biggest one-day pct decline since Oct. 14
** Stock on track to snap two consecutive sessions of gain
** The Chinese biotechnology group plans sale of 33.15 mln new shares, representing 8.14% of the enlarged share capital, to third party investors, raising HK$233.71 mln ($30.03 mln) to fund clinical studies for treatment of solid tumors in China
** The new shares will be issued at HK$7.05 apiece, or 16.27% discount to Wednesday's close of HK$8.42
** Hang Seng Commerce & Industry Index .HSNC slips 0.1%, while healthcare index .HSCIH and Hang Seng Index .HSI each eases 0.3%
** Stock down 73.9% YTD
($1 = 7.7826 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。